Clinical Trials

Classical hematologyGynecologic

12 enrolled

Ovarian Neoplasms, Recurrence, Thrombocytopenia

NCT06972693 2025-05-15

PERSONA-Ovary

Phase 4 Active not recruiting

323 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03164980 2025-03-20

COMPASS

89 enrolled 20 charts

Phase 4 Not yet recruiting

Ovarian Neoplasms, Recurrence

NCT06871787 2025-03-14

INOCA

50 enrolled

Uterine Cervical Neoplasms, Ovarian Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Anastomotic Leak

NCT03752216 2024-12-13

NiQoLe

141 enrolled

Ovarian Neoplasms

NCT03858166 2024-01-05

Efficacy and Safety of PEG-rhG-CSF Secondary Prophylaxis vs. Therapeutic Administration in Patients With Ovarian Cancer

68 enrolled

Ovarian Neoplasms

NCT05949424 2023-11-29

OPTI-DOSE

BreastGenitourinaryGynecologicHead & Neck

30 enrolled

Breast Neoplasms, Carcinoma, Renal Cell, Ovarian Neoplasms, Thyroid Neoplasms, Endometrial Neoplasms

NCT05926336 2023-09-28

The Effects of Using Different Anesthetics on the Prognosis of Primary Tumors and Its Mechanism of Action

Phase 4 Recruiting

1,316 enrolled

CNSGastrointestinalGynecologicThoracic

Brain Neoplasms, Liver Neoplasms, Lung Neoplasms, Ovarian Neoplasms

NCT05606692 2023-05-30

anesthetics

Phase 4 Recruiting

416 enrolled

Ovarian Neoplasms

NCT01706120 2023-03-24

MITO16/MANGO-2

400 enrolled

Ovarian Neoplasms

NCT00740116 2022-03-15

Tranexamic Acid in Surgery of Advanced Ovarian Cancer

100 enrolled 11 charts

Ovarian Neoplasms, Thromboembolism, Blood Loss, Surgical, Postoperative Hemorrhage

NCT05187208 2022-01-26

POLO

102 enrolled

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT01953107 2021-05-12

Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates.

Classical hematologyGynecologic

200 enrolled

Anemia, Uterine Cervical Neoplasms, Ovarian Neoplasms, Uterine Neoplasms

NCT03475589 2020-05-12

Study on the Adverse Drug Reactions (ADRs) of Apatinib and Their Biomarker Correlations

217 enrolled

Neoplasms, Ovarian Neoplasms

NCT03384511 2018-02-20

The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.

BreastGastrointestinalGynecologicThoracic

38 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

NCT01432015 2017-03-28

Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting

20 enrolled 5 charts

Ovarian Neoplasms, Uterine Neoplasms, Vomiting

NCT02035345 2016-12-08

Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-Treatment

15 enrolled 9 charts

Ovarian Neoplasms

NCT00817479 2016-07-13

Tumor Gene Expression in Women With Ovarian Cancer

20 enrolled 5 charts

Ovarian Neoplasms

NCT02243059 2015-09-28

MILO

Phase 4 Withdrawn